Inventor
Peter J. Sims
Inventor
Mequon, WI, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides26%
A01KAnimal husbandry14%
C12NMicroorganisms or enzymes11%
A61LMethods or apparatus for sterilising materials or objects in general9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations2%
B23KSoldering or unsoldering2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
11,035,001Single cell nucleic acid detection and analysis20217,166,568'Compositions and methods to inhibit formation of the C5b-9 complex of complement'20076,916,654'Universal donor cells'20056,534,640'Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids'20036,204,035'Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids'20016,172,210'DNA encoding phospholipid scramblase'20016,100,443'Universal donor cells'20005,955,441'Genetic inhibition of complement mediated inflammatory response'19995,886,314'Pipe cutting apparatus'19995,843,884'C9 complement inhibitor'19985,763,156'Inhibition of complement mediated inflammatory response'19985,705,732'Universal donor cells'19985,660,825'Method of inhibition of complement mediated inflammatory response'19975,635,178'Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex'19975,573,940'Cells expressing high levels of CD59'19965,550,108'Inhibition of complement mediated inflammatory response'19965,135,916'Inhibition of complement mediated inflammatory response'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2007Patents assigned to OKLAHOMA MED RES FOUND (11)· patent assignee history
1992–1999Based in Oklahoma City, OK, US· patent location history
1996–2005Patents assigned to UNIV YALE (5)· patent assignee history
1996–2007Based in Mequon, WI, US· patent location history
1999Based in Waterford Qld 4133, AU· patent location history
2001–2003Patents assigned to BLOOD CT RES FOUNDATION (3)· patent assignee history
2021Patents assigned to HARVARD COLLEGE (1)· patent assignee history
2021Based in Cambridge, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OKLAHOMA MED RES FOUND | 11 | 1992–2007 |
| UNIV YALE | 5 | 1996–2005 |
| BLOOD CT RES FOUNDATION | 3 | 2001–2003 |
| HARVARD COLLEGE | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mequon, WI, US | 9 | 1996–2007 |
| Oklahoma City, OK, US | 6 | 1992–1999 |
| Cambridge, Massachusetts, US | 1 | 2021 |
| Waterford Qld 4133, AU | 1 | 1999 |